Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Clinical trial NCT06637306 · RECRUITING

Trial details

NCT number: NCT06637306
Sponsor: Rima Patel
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Locally Advanced Triple Negative Breast Cancer TNBC - Triple-Negative Breast Cancer

Start date: 2025-03-05
Primary completion: 2027-03-10
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.